Nippon Kayaku Co., Ltd.

15 articles about Nippon Kayaku Co., Ltd.

• AnHeart Therapeutics Announces Exclusive License Agreement With Nippon Kayaku for Taletrectinib in Japan

  10/30/2023

  AnHeart Therapeutics today announced it has entered into an exclusive license agreement with Nippon Kayaku Co., Ltd (“Nippon Kayaku”) to market and distribute AnHeart’s lead investigational therapy, taletrectinib, in Japan.

• Solasia and Nippon Kayaku Announce License Agreement in Japan for New Drug Candidate DARINAPARSIN (SP-02)

  10/26/2021

  Solasia Pharma K.K. and Nippon Kayaku Co., Ltd. jointly announced the conclusion of a license agreement for marketing rights to darinaparsin in Japan.

• Debiopharm Has Won Its Patent Infringement Suit For Elplat Against Nippon Kayaku Co., Ltd.

  3/4/2016

• Eiger Biopharma Announces License Agreement With Nippon Kayaku Co., Ltd. To Develop Bestatin (ubenimex) For Inflammatory Diseases Involving LTB4

  11/9/2015

• Spectrum Pharmaceuticals, Inc. Announces Initiation of a Required Phase 1 Study of Apaziquone in Japan by Nippon Kayaku Co., Ltd.

  1/6/2011

• Spectrum Pharmaceuticals, Inc. Announces Receipt of $16 Million from Asian Partners, Such As Nippon Kayaku Co., Ltd. Related to Apaziquone Collaboration Agreements Announced in November 2009

  1/29/2010

• Spectrum Pharmaceuticals, Inc. and Nippon Kayaku Co., Ltd. Enter Collaboration Agreement for Apaziquone in Asian Territories

  11/10/2009

• BioSphere Medical, Inc. Enters into Exclusive Distribution Agreement with Nippon Kayaku Co., Ltd. for Japanese Market

  4/16/2009

• Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes

  7/17/2008

• NeoPharm Says Japan's Nippon Kayaku Co., Ltd. Terminates License Agreement

  9/14/2007

• Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. To Release Cetrotide In Japan

  9/21/2006

• Spectrum Pharmaceuticals, Inc. Announces A License And Collaboration Agreement For Ozarelix With Nippon Kayaku Co., Ltd. For The Japanese Market

  8/4/2006

• AEterna Zentaris Enters A License And Collaboration Agreement For Ozarelix With Nippon Kayaku Co., Ltd. For The Japanese Market

  8/3/2006

• Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. Receive Approval For Cetrotide

  4/21/2006

• Nippon Kayaku Co., Ltd. To Merge Two Consolidated Subsidiaries In June

  3/3/2006